AlphaFold predicted structure
GAD1 · Q99259

Mean pLDDT
88.7/ 100
Confident
594 residues
Confidence breakdown
- Very high(≥ 90)83%
- Confident(70–90)2%
- Low(50–70)1%
- Very low(< 50)14%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
glutamate decarboxylase 1
Annotations refreshed 10 hours ago.
Diagnostic Grade (Green)
Early onset or syndromic epilepsy
BIALLELIC, autosomal or pseudoautosomalIntellectual disability
BIALLELIC, autosomal or pseudoautosomalAdult onset hereditary spastic paraplegia
BIALLELIC, autosomal or pseudoautosomalChildhood onset hereditary spastic paraplegia
BIALLELIC, autosomal or pseudoautosomalAdult onset neurodegenerative disorder
UnknownCOVID-19 research
BIALLELIC, autosomal or pseudoautosomalDDG2P
BIALLELIC, autosomal or pseudoautosomalHereditary spastic paraplegia
+1 more panels — install the extension to see the full list inline on any page.
developmental and epileptic encephalopathy 89
Inherited congenital spastic tetraplegia
neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities
intelligence
type 2 diabetes mellitus
mathematical ability
stroke disorder
alcohol drinking
hereditary disease
glomerulonephritis
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Glutamate decarboxylase 1
Catalyzes the synthesis of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA) with pyridoxal 5'-phosphate as cofactor
GAD1 · Q99259

Mean pLDDT
88.7/ 100
Confident
594 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0